Walgreens Shares Crash 24%—On Track For Worst Day Since 1970s
Shares for Walgreens fell over 24% on Thursday, pacing the company's worst loss since at least 1972, after the pharmacy chain announced lower-than-expected quarterly earnings and “significant” store closures.
EVSM Brings Track Record of Outperformance to ETF Investors
The first half of 2024 saw increased mutual fund to ETF conversions. These funds bring the benefits of established track records to ETF investors.
RSST: Solid Futures ETF, Good Performance Track-Record, Potential Source Of Diversification
RSST provides exposure to U.S. large-cap equities and a managed futures strategy. The fund's strategy has been broadly effective in the past, with strong returns and moderate risk. I'm bullish, but think position sizes should be kept small, to reduce risk.
Wall Street On Track To Resume Meteoric Climb, Nvidia Builds On Gains: Analyst Says 'Now Until Later In The Month Is
U.S. stocks will likely carry over from where they left off as the market reopens after the Juneteenth holiday on Thursday. The major index futures were all uniformly higher, underpinned by the continued buoyancy in the tech space.
Is Disney Animation Back on Track?
A huge opening weekend for Inside Out 2 is a great sign for Disney.
Contineum: LPA1R Antagonist Drug Advancement Against IPF With Proven Track Model
Contineum Therapeutics, Inc. PIPE-791 is being developed for the treatment of neuroinflammatory disorders like idiopathic pulmonary fibrosis and Progressive Multiple Sclerosis. The global idiopathic pulmonary fibrosis market size is projected to reach $6.45 billion by 2031. The global multiple sclerosis drugs market size is projected to reach $38.94 billion by 2032.
Have $10,000? 3 Growth Stocks on Track to Double by 2028
Growth stocks have always captured investors' attention due to their potential for explosive returns. As we look ahead to 2028, several growth stocks will potentially double in value.
Tiziana Life Sciences seeks FDA Fast Track Designation for foralumab in MS treatment
Tiziana Life Sciences Ltd (NASDAQ:TLSA), said it is seeking Fast Track Designation approval from the US Food and Drug Administration (FDA) for its intranasal foralumab therapy to treat non-active, secondary-progressive multiple sclerosis (na-SPMS). Foralumab, a fully human anti-CD3 monoclonal antibody, has demonstrated the ability to induce T regulatory cell production when administered intranasally.
Up 70% for the Year and On Track to Hit a New All-Time High, Is Ethereum a Buy?
Investors are counting on the approval of new spot Ethereum ETFs to send the crypto soaring higher. The ETF investment thesis for Ethereum may be getting overhyped.
Evolution AB: Thesis Still On Track
Evolution AB is a B2B provider of live casino solutions and RNG games in the iGaming industry. The stock has underperformed, but the fundamental thesis remains intact, with strong growth potential. Q4 2023 and Q1 2024 reports show continued strong revenue growth and Evolution's North America expansion remains on track.
On Track to Double: 2 Bargain Stocks to Buy Now
AT&T and Fiverr are trading at discounted valuations. AT&T has been consistently growing its wireless and fiber businesses, and it's churning out mountains of free cash flow each year.
Nvidia on Track to Become Second-Most Valuable Company
Nvidia's role in the artificial intelligence market could reportedly make it the world's second-most valuable company. The chip maker could overtake Apple to assume the position, behind No.
